Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
Matthew R Sydes
, Melissa Spears
, Malcolm Mason
, Noel Clarke
, David P. Dearnaley
, Johann de Bono
, Gerhardt Attard
, Simon Chowdhury
, William Cross
, Silke Gillessen Sommer
, Zaf Malik
, Rob Jones
, Chris Parker
, Alastair W.S Ritchie
, J Martin Russell
, Robin Millman
, David Matheson
, C Amos
, Clare Gilson
, Alison Birtle
Samantha Brock, Lisa Capaldi, P Chakraborti, Ananya Choudhury, L. Evans, D Ford, Joanna Gale, Stephanie Gibbs, Duncan C. Gilbert, Robert Hughes, Duncan McLaren, Jason Lester, Ashok Nikapota, Joe O'Sullivan, Omi Parikh, C Peedell, Andrew Protheroe, S. Rudman, Richard Shaffer, Denise Sheehan, Matthew Simms, Narayanan Srihari, R Strebel, Santhanam Sundar, Shaun Tolan, David Tsang, Mohini Varughese, John Wagstaff, Mahesh K B Parmar, Nicholas James
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol'. Together they form a unique fingerprint.